The major analytical and bioanalytical services are method development, method validation and sample analysis. This article examines published analytical as well as bioanalytical methods that are reported so far for the determination of teneligliptin (an antidiabetic drug) in pharmaceutical formulations and biological fluid/samples. They include various methods such as spectrophotometric method, high performance liquid chromatography, ultra-fast liquid chromatography (UFLC) with PDA detector, UPLC with tandem mass spectroscopy (LC/MS/MS), ultra- performance liquid chromatography-Diode Array Detectors (UHPLC-DAD), liquid chromatography-electro spray ionization-tandem mass spectroscopy (LC-ESI-MS), liquid chromatography-mass spectroscopy (LC-MS) and high performance thin layer chromatography (TLC). The article incorporates various reported methods developed to help analysts in choosing crucial parameters for new method development of teneligliptin.
Loading....